Not Medicare Enrolled

Dr. Fang Wang, D.O.

Rheumatology · Plano, TX
4625 MEADOW RIDGE DR, Plano, TX 75093
2146634029
Registered in NPPES since 2007
NPI: 1689865289 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wang

Dr. Fang Wang is a rheumatology specialist in Plano, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Wang received a total of $5,929 from 33 pharmaceutical and/or device companies across 233 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wang is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $5,929 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,929
Total received (2018-2024)
Avg $847/year across 7 years
Top 42% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
233
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$830
2023
$1,080
2022
$936
2021
$1,197
2020
$311
2019
$1,055
2018
$519

Payments by company (2024)

ABBVIE INC.
$319
GlaxoSmithKline, LLC.
$112
Mannkind Corporation
$89
PFIZER INC.
$89
Amgen Inc.
$84
Davol Inc.
$34
Stryker Corporation
$30
AstraZeneca Pharmaceuticals LP
$29
Phathom Pharmaceuticals, Inc.
$25
Janssen Biotech, Inc.
$18
Top 3 companies account for 62.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$934
Amgen Inc.
$825
ABBVIE INC.
$603
PFIZER INC.
$518
Genentech USA, Inc.
$492
GlaxoSmithKline, LLC.
$406
AstraZeneca Pharmaceuticals LP
$310
Amarin Pharma Inc.
$238
Lilly USA, LLC
$184
AbbVie, Inc.
$175
Esperion Therapeutics, Inc.
$150
Janssen Biotech, Inc.
$150
Bayer Healthcare Pharmaceuticals Inc.
$137
Horizon Therapeutics plc
$120
Mannkind Corporation
$89
Gilead Sciences, Inc.
$88
UCB, Inc.
$67
IDORSIA PHARMACEUTICALS US INC
$58
Horizon Pharma plc
$47
Boehringer Ingelheim Pharmaceuticals, Inc.
$46
VBI Vaccine (Delaware) Inc.
$41
Davol Inc.
$34
Stryker Corporation
$30
Phathom Pharmaceuticals, Inc.
$25
Valeritas, Inc.
$25
Novartis Pharmaceuticals Corporation
$21
SI-BONE, Inc.
$20
Abbott Laboratories
$19
Takeda Pharmaceuticals U.S.A., Inc.
$19
Eisai Inc.
$18
Mallinckrodt Hospital Products Inc.
$15
Novo Nordisk Inc
$13
IBSA Pharma Inc.
$11
Top 3 companies account for 39.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFREZZA · Actemra · BEXSERO · BREZTRI · CONFIRM RX · COSENTYX · Cimzia · DERMACELL · Dayvigo · EMGALITY · EVENITY · Enbrel · FARXIGA · HUMIRA · Humira · JARDIANCE · Kerendia · LYRICA · MOUNJARO · NEXLETOL · NEXLIZET · Otezla · Ozempic · PAXLOVID · PENNSAID · Phasix Mesh · PreHevbrio · Prolia · QULIPTA · QUVIVIQ · RAYOS · REMICADE · RINVOQ · Repatha · Rinvoq · SHINGRIX · SKYRIZI · TAVNEOS · TRELEGY ELLIPTA · TREMFYA · TRULICITY · Tirosint · UBRELVY · V-GO · VOQUEZNA · VYVANSE · Vascepa · Vemlidy · XELJANZ · Xofluza
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Plano?
Compare rheumatologists in the Plano area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
95
County median income
$117,588
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wang is a rheumatology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $5,929 from 33 companies across 233 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Rheumatologists in Plano
Browse rheumatologists in Plano ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →